Baxter Healthcare Articles
Genmab sells US manufacturing facility to Baxter
1 March 2013
Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body
29 April 2011
Merck KGaA sells women’s health business to Teva in $368 million-euro deal; Hikma buys Baxter’s injectable business for $112 million
29 October 2010
Teva and Baxter to pay $500 million in punitive damages, Nevada court rules; Teva settles with Watson
10 May 2010
Showing 1-4 of 4 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
